Federated Hermes’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-522
| Closed | -$1K | – | 2299 |
|
|
2022
Q2 | $1K | Buy |
+522
| New | +$384 | ﹤0.01% | 2124 |
|
|
2020
Q4 | – | Sell |
-935
| Closed | -$11K | – | 2381 |
|
|
2020
Q3 | $11K | Sell |
935
-2,522
| -73% | -$33.8K | ﹤0.01% | 1960 |
|
|
2020
Q2 | $56K | Sell |
3,457
-99,658
| -97% | -$1.74M | ﹤0.01% | 1768 |
|
|
2020
Q1 | $1.6M | Buy |
103,115
+74,936
| +266% | +$1.61M | ﹤0.01% | 962 |
|
|
2019
Q4 | $693K | Buy |
28,179
+27,616
| +4,905% | +$410K | ﹤0.01% | 1368 |
|
|
2019
Q3 | $6K | Sell |
563
-55,157
| -99% | -$696K | ﹤0.01% | 1940 |
|
|
2019
Q2 | $699K | Buy |
55,720
+54,944
| +7,080% | +$707K | ﹤0.01% | 1378 |
|
|
2019
Q1 | $10K | Buy |
776
+7
| +0.9% | +$78 | ﹤0.01% | 1878 |
|
|
2018
Q4 | $5K | Sell |
769
-361
| -32% | -$2.76K | ﹤0.01% | 1987 |
|
|
2018
Q3 | $12K | Sell |
1,130
-79,228
| -99% | -$904K | ﹤0.01% | 1933 |
|
|
2018
Q2 | $1.09M | Buy |
80,358
+55,135
| +219% | +$858K | ﹤0.01% | 1263 |
|
|
2018
Q1 | $448K | Buy |
25,223
+22,824
| +951% | +$385K | ﹤0.01% | 1413 |
|
|
2017
Q4 | $30K | Sell |
2,399
-40,621
| -94% | -$590K | ﹤0.01% | 1720 |
|
|
2017
Q3 | $820K | Sell |
43,020
-46,485
| -52% | -$709K | ﹤0.01% | 1250 |
|
|
2017
Q2 | $1.35M | Buy |
89,505
+74,009
| +478% | +$1.12M | ﹤0.01% | 1101 |
|
|
2017
Q1 | $266K | Buy |
+15,496
| New | +$206K | ﹤0.01% | 1451 |
|
Other funds holding EPZM
Federated Hermes's EPZM Position: Q3 2022 in Review
Federated Hermes sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 522 shares — an estimated $1K sold.
Federated Hermes first reported a position in EPZM in Q1 2017 and held it in 16 quarters. The position peaked at $1.6M in Q1 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Federated Hermes reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Federated Hermes sold 522 Epizyme, Inc shares in Q3 2022, an estimated $1K.
- Federated Hermes first reported a position in Epizyme, Inc in Q1 2017 and held it in 16 quarters.
- Federated Hermes's Epizyme, Inc position peaked at $1.6M in Q1 2020.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.